These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. A case control study of glycoprotein status in ovarian carcinoma. Aranganathan S, Senthil K, Nalini N. Clin Biochem; 2005 Jun; 38(6):535-9. PubMed ID: 15885233 [Abstract] [Full Text] [Related]
6. [Sialic acid and carcinoembryonic antigen (CEA) as markers of colon cancer: Preliminary report]. Dabrowska B, Krasnodebski IW, Tadeusiak W. Pol Tyg Lek; 2005 Jun; 46(45-47):890-1. PubMed ID: 1669462 [Abstract] [Full Text] [Related]
7. Clinical significance of total and lipid bound sialic acid levels in oral pre-cancerous conditions and oral cancer. Rajpura KB, Patel PS, Chawda JG, Shah RM. J Oral Pathol Med; 2005 May; 34(5):263-7. PubMed ID: 15817068 [Abstract] [Full Text] [Related]
8. Serum fucosylation changes in oral cancer and oral precancerous conditions: alpha-L-fucosidase as a marker. Shah M, Telang S, Raval G, Shah P, Patel PS. Cancer; 2008 Jul 15; 113(2):336-46. PubMed ID: 18521898 [Abstract] [Full Text] [Related]
9. Correlation of serum biomarkers (TSA & LSA) and epithelial dysplasia in early diagnosis of oral precancer and oral cancer. Sawhney H, Kumar CA. Cancer Biomark; 2008 Jul 15; 10(1):43-9. PubMed ID: 22297551 [Abstract] [Full Text] [Related]
10. Importance of serum sialic acid and lactate dehydrogenase in diagnosis and treatment monitoring of cervical cancer patients. Patel PS, Rawal GN, Balar DB. Gynecol Oncol; 1993 Sep 15; 50(3):294-9. PubMed ID: 8406190 [Abstract] [Full Text] [Related]
11. Biochemical markers in ovarian cancer. Kiricuta I, Bojan O, Munteanu S. Arch Geschwulstforsch; 1986 Sep 15; 56(1):35-8. PubMed ID: 3964031 [Abstract] [Full Text] [Related]
12. [N-acetylneuraminic acid (sialic acid) as a tumor marker in head and neck cancers]. Fischer F, Egg G. HNO; 1990 Oct 15; 38(10):361-3. PubMed ID: 2283329 [Abstract] [Full Text] [Related]
13. Plasma lipid-associated sialic acid and serum CA 125 as indicators of disease status with advanced ovarian cancer. Vardi JR, Tadros GH, Foemmel R, Shebes M. Obstet Gynecol; 1989 Sep 15; 74(3 Pt 1):379-83. PubMed ID: 2761915 [Abstract] [Full Text] [Related]
14. [Usefulness of sialic acid as a tumor marker]. Feliú J, Daimiel E, Vicente J, Martín G, García Girón C, Chacón I, González Barón M. Rev Clin Esp; 1989 May 15; 184(8):401-3. PubMed ID: 2781072 [Abstract] [Full Text] [Related]
15. Diagnostic and prognostic role of plasma and urinary sialic acid in human carcinoma of uterine cervix. Balasubramaniyan N, Subramanian S, Sekar N, Bhuvarahamurthy V, Govindasamy S. Biochem Mol Biol Int; 1994 Jul 15; 33(4):617-23. PubMed ID: 7981648 [Abstract] [Full Text] [Related]
16. Estimation and comparative study of serum total sialic acid levels as tumor markers in oral cancer and precancer. Joshi M, Patil R. J Cancer Res Ther; 2010 Jul 15; 6(3):263-6. PubMed ID: 21119250 [Abstract] [Full Text] [Related]
17. Circulating levels in serum of total sialic acid, lipid-associated sialic acid, and fucose in precancerous lesion and cancer of the oral cavity. Rao VR, Krishnamoorthy L, Kumaraswamy SV, Ramaswamy G. Cancer Detect Prev; 1998 Jul 15; 22(3):237-40. PubMed ID: 9618045 [Abstract] [Full Text] [Related]
19. Significance of serum fucose, sialic acid, haptoglobine and phospholipids levels in the evolution and treatment of breast cancer. Kiricuta I, Bojan O, Comes R, Cristian R. Arch Geschwulstforsch; 1979 Jul 15; 49(2):106-12. PubMed ID: 475547 [Abstract] [Full Text] [Related]